Oxford covid vaccine: Serum Institute expects emergency authorization next month
4 years, 1 month ago

Oxford covid vaccine: Serum Institute expects emergency authorization next month

Live Mint  

The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month. If final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- which is partnered to produce at least one billion doses -- may get emergency authorization from New Delhi by December, said Adar Poonawalla, chief executive officer of the family-owned firm based in the Pune. Serum, which has tied up with five developers, has so far made 40 million doses of AstraZeneca’s vaccine in the past two months and aims to start manufacturing Novavax Inc.’s contender soon. But both AstraZeneca-Oxford University and Novavax’s shots “are looking pretty good.” The haste underlines Poonawalla’s confidence in one of the main vaccine front-runners.

India World Covid Million Vaccine Oxford Serum Poonawalla Serum Institute Billion Shot Expects Emergency  oxford  india  million  world  covid  effective  billion  shot  month  authorization  vaccine  poonawalla  doses  serum  expects  emergency  institute

History of this topic

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

With State prod, India can be world leader in vaccines
11 months, 2 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years
1 year, 3 months ago

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years

The Hindu  

A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill and Melinda Gates Foundation announced Monday. “Whether it's for local diseases in Africa like Rift Valley or for global diseases like TB, mRNA looks like a very promising …

US govt awards $1.4 bln for development of new COVID...
1 year, 4 months ago

US govt awards $1.4 bln for development of new COVID...

Daily Mail  

The Biden Administration has allocated another $1.4billion to developing Covid treatments and vaccines – despite declaring the pandemic over months ago. The news comes as hospitalizations rise for the fifth week in a row, though they are still three times lower than this time last year. Hospitalizations across the US have risen for the fifth week in a row, but …

Axed Covid vaccine contract cost taxpayers £358m
1 year, 6 months ago

Axed Covid vaccine contract cost taxpayers £358m

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A biotechnology company which had its contract to make Covid …

COVID-19 vaccine maker Novavax to chop workforce, expenses
1 year, 8 months ago

COVID-19 vaccine maker Novavax to chop workforce, expenses

Associated Press  

Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general and administrative expenses by about 40% to 50% compared to 2022. A Novavax representative …

Serum Institute to double investment in Biocon’s unit to $300 million
1 year, 8 months ago

Serum Institute to double investment in Biocon’s unit to $300 million

Live Mint  

As part of its expansion of investment in one of Biocon Ltd's units, Serum Institute of Life Sciences will give it access to 100 million vaccine doses annually. As per the new alliance, the company would pump in $150 million after converting a loan to Biocon Pharma Limited into equity in Biocon Biologics Ltd. The investment made is in addition …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year
1 year, 11 months ago

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. A year earlier the business sold 1.8 billion US …

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
2 years ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times  

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
2 years ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

GAVI financing to allow for immediate funds for next pandemic
2 years, 3 months ago

GAVI financing to allow for immediate funds for next pandemic

Live Mint  

Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters. Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

AstraZeneca and Pfizer Vaccines Saved Over 1.2 Crore Lives in First Year: Study
2 years, 5 months ago

AstraZeneca and Pfizer Vaccines Saved Over 1.2 Crore Lives in First Year: Study

News 18  

The AstraZeneca and Pfizer COVID-19 vaccines saved over 1.2 crores lives, while India's indigenous Covaxin averted over 3.7 lakh deaths in the first year of the global immunisation campaign, according to a modelling study. Last month, a study on excess deaths from 185 countries and territories by the Imperial College London, UK, calculated that COVID-19 vaccines saved around 2 crore …

Adar Poonawalla’s Pitch for Pandemic Treaty at Davos, Says Might Have to Destroy Covid Jab Doses
2 years, 7 months ago

Adar Poonawalla’s Pitch for Pandemic Treaty at Davos, Says Might Have to Destroy Covid Jab Doses

News 18  

Serum Institute of India chief executive officer Adar Poonawalla, in an interview to Shereen Bhan of CNBC-TV18, on Monday said he is advocating a global pandemic treaty, and has proposed that there should be a framework for leaders to work with. Stressing that there is an “oversupply” of Covid-19 vaccines in the world, Poonawalla, on the sidelines of the World …

SII Lowers Each Dose of Covovax Jab from Rs 900 to Rs 225 Excluding Taxes
2 years, 8 months ago

SII Lowers Each Dose of Covovax Jab from Rs 900 to Rs 225 Excluding Taxes

News 18  

A day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the Serum Institute of India on Tuesday reduced the price of each dose of the vaccine from Rs 900 to Rs 225, excluding taxes. On Tuesday, Director for Government and Regulatory Affairs, SII, Prakash Kumar Singh, …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 8 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

How govt spent Rs 35,000 crore on procuring Covid-19 vaccines | RTI Exclusive
2 years, 8 months ago

How govt spent Rs 35,000 crore on procuring Covid-19 vaccines | RTI Exclusive

India Today  

The Ministry of Health announced last week that the precautionary third dose of Covid-19 vaccine would be available for the age group of 18-59 years on payment at private centres from April 10. In response to our query dated February 4, 2022, the Department of Health and Family Welfare said, "As per the announcement in Parliament during Budget session 2021, …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Covishield, Covaxin to now cost private hospitals Rs 225 per dose
2 years, 9 months ago

Covishield, Covaxin to now cost private hospitals Rs 225 per dose

India Today  

A single dose of the Serum Institute of India's Covishield and Bharat Biotech's Covaxin will now cost private hospitals Rs 225. Adar Poonawalla, CEO of SII, said in a tweet on Saturday that the vaccine maker has decided to slash the prices of the Covid-19 jab for private hospitals from Rs 600 to Rs 225 after consultation with the central …

Covishield booster shots to be priced at ₹600 plus taxes: Adar Poonawalla
2 years, 9 months ago

Covishield booster shots to be priced at ₹600 plus taxes: Adar Poonawalla

Hindustan Times  

The Union health ministry announced on Friday that beginning April 10, booster doses will be available to all adults at private Covid-19 vaccine centres. Soon after, Serum Institute of India CEO Adar Poonawalla said Covishield precautionary for all adults will be priced at ₹600 per shot plus taxes. Meanwhile, Covovax - which has not been formally announced as a booster …

Breaking News, March 25
2 years, 9 months ago

Breaking News, March 25

India TV News  

Against the estimated population of 101.3 crore beneficiaries aged 15 years and above, a total of 181.24 crore doses of COVID-19 vaccines were administered in the country as on March 21, the government informed Parliament on Friday. In a written reply to a question in the Lok Sabha, Union Health Minister Mansukh Mandaviya said a total of 9.71 crore first …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

Op-Ed: What will it take to make a universal COVID vaccine?
2 years, 9 months ago

Op-Ed: What will it take to make a universal COVID vaccine?

LA Times  

As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to avoid the variant. Since this protein is so prone to mutation, making it harder for the body to recognize in future variants, a more universal vaccine must target parts of the virus that are shared among several viruses in the …

UK pledges £160m to help accelerate vaccine development
2 years, 10 months ago

UK pledges £160m to help accelerate vaccine development

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Foreign Secretary Liz Truss said: …

Union Budget 2022: Why Centre has reduced COVID-19 vaccine budget to Rs 5,000 crore
2 years, 11 months ago

Union Budget 2022: Why Centre has reduced COVID-19 vaccine budget to Rs 5,000 crore

Firstpost  

Experts are of the opinion that the reduction in allocation of funds hints that the Centre has done its job of providing free vaccines across the country and people may have to shell out for booster shots The proposal of Rs 5,000 crore COVID-19 vaccination Budget for this year hints that the Centre has done its job of providing free …

Govt Slashing Covid Vax Budget Could Mean People Buying Booster Dose on Their Own, Say Experts
2 years, 11 months ago

Govt Slashing Covid Vax Budget Could Mean People Buying Booster Dose on Their Own, Say Experts

News 18  

The proposal of Rs 5,000 crore Covid-19 vaccination Budget for this year hints that the Centre has done its job of providing free vaccines across the country and people may have to shell out for booster shots, according to experts. Rs 5,000 crore Enough for Jabbing Remaining Population According to health and public policy experts, the budget of Rs 5,000 …

Two COVID vaccines may cost Rs. 275 after market nod
2 years, 11 months ago

Two COVID vaccines may cost Rs. 275 after market nod

Deccan Chronicle  

NEW DELHI: In a bid to make vaccines against Covid-19 affordable, prices of Covishield and Covaxin jabs are likely to be capped at Rs 275 per dose, with an additional service charge of Rs 150. Serum Institute of India director Prakash Kumar Singh had submitted an application to the DCGI on October 25 seeking regular market approval for its Covishield …

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
3 years ago

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin

Live Mint  

The Gavi vaccine alliance is in talks with India's Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told Reuters on Thursday. The World Health Organization in November gave Covaxin, India's first homegrown COVID-19 vaccine, approval for emergency use. Gavi said it was also working with the Serum …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
3 years ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022
3 years ago

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

News 18  

Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. “Biological E. Limited plans to complete production at a …

Over 148.37 crore COVID-19 vaccine doses provided to states and UTs so far, says Centre
3 years ago

Over 148.37 crore COVID-19 vaccine doses provided to states and UTs so far, says Centre

Firstpost  

The health ministry said more than 17.72 crores balance and unutilised coronavirus vaccine doses are still available with the states and UTs to be administered New Delhi: In the ongoing nationwide vaccination drive against COVID-19, the Centre has provided more than 148.37 crore vaccine doses to States and Union Territories so far, the Union Ministry of Health and Family Welfare …

India gears up to vaccinate kids, administer booster jabs, likely to procure 58 crore doses
3 years ago

India gears up to vaccinate kids, administer booster jabs, likely to procure 58 crore doses

India Today  

India has activated its share of vaccine doses in the COVAX alliance to make more doses available as the country moves to include children and populations eligible for precautionary additional doses even as Omicron cases continue to surge. Read | Bharat Biotech's Covaxin gets approval for emergency use for children aged 12, above BIOLOGICAL E AT RISK STOCK PILED DOSES …

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt
3 years ago

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt

News 18  

India has supplied 983.068 lakh doses of COVID-19 vaccine to 94 countries and two United Nations entities in the form of grant, commercial export or through COVAX till December 15 since the start of Vaccine Maitri programme in January, 2021, the Rajya Sabha was told on Tuesday. The country supplied COVID-19 related medical and other assistance to over 150 countries …

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48
3 years ago

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48

News 18  

As the World Health Organization grants an emergency approval to Serum Institute of India’s Covovax, a top Indian government scientist has recommended that it be used as a booster shot to counter the threat posed by the emerging omicron variant of coronavirus, India Today reported. French Prime Minister Jean Castex says the Omicron variant will be the dominant strain of …

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO
3 years ago

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO

Firstpost  

Adar Poonawalla, the CEO of Serum Institute of India, hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. New Delhi: The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the …

Serum Institute-Novovax's Covid Vaccine Covovax Gets Emergency Use Listing from WHO
3 years ago

Serum Institute-Novovax's Covid Vaccine Covovax Gets Emergency Use Listing from WHO

News 18  

The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the viral disease. According to WHO, Covovax was assessed under its emergency use listing procedure based on the review of data on quality, safety …

COVID: Over 16.42 crore vaccine doses available with states, UTs
3 years ago

COVID: Over 16.42 crore vaccine doses available with states, UTs

India TV News  

Highlights Over 141.80 cr vaccine doses have been provided to states, UTs so far through Govt of India Union govt is committed to accelerating pace, expanding scope of COVID vaccination throughout India Govt of India has been supporting states, UTs by providing them COVID vaccines free of cost Over 16.42 crore Covid vaccine doses are still available with states and …

Serum Institute pledges over $66 million to Oxford University for vaccine research centre
3 years ago

Serum Institute pledges over $66 million to Oxford University for vaccine research centre

Firstpost  

The main focus of the research taking place in the Poonawalla Building will be vaccinology and it will house over 300 research scientists The Serum Institute of India has pledged £50 million to the University of Oxford for setting up the Poonawalla Vaccines Research Building at the University of Oxford. The Poonawalla Vaccines Research Building will be built on the …

Vaccine maker SII pledges $66 million to Oxford University
3 years ago

Vaccine maker SII pledges $66 million to Oxford University

Hindustan Times  

Vaccine maker Serum Institute of India has pledged 50 million pounds to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot. The pledge builds on the collaboration between Oxford University, AstraZeneca and SII The investment was made through the Indian company's Serum Life Sciences unit, Oxford University said …

Variants, boosters turn rich-poor vaccine gap into chasm
3 years, 1 month ago

Variants, boosters turn rich-poor vaccine gap into chasm

Associated Press  

PARIS — The global initiative to share coronavirus vaccines fairly already scaled back its pledge to the world’s poor once. Now, to meet even that limited promise, COVAX would have to deliver more than a million doses every hour until the end of the year in some of the world’s most challenging places. COVAX’s new promise is for 1.4 billion …

India’s Serum Institute resumes vaccine exports to COVAX
3 years, 1 month ago

India’s Serum Institute resumes vaccine exports to COVAX

Al Jazeera  

The world’s largest vaccine maker halted shipments of COVID shots in March as India saw an explosion in infections. The Serum Institute of India, the world’s largest vaccine maker, has resumed exports of coronavirus vaccines to the UN-backed COVAX distribution programme after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 …

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla
3 years, 1 month ago

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla

News 18  

Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat in overcoming the COVID-19 pandemic while urging all adults to get vaccinated at the earliest. He said that 200 million doses of the COVID-19 vaccine were lying with the states and people should get themselves vaccinated as soon as possible. Vaccine hesitancy is now …

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December
3 years, 2 months ago

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December

News 18  

A batch of Hyderabad-based pharmaceutical firm Biological E’s Covid vaccine Corbevax has been cleared by the country’s apex testing laboratory in Himachal Pradesh, paving the way for the manufacturer to start stockpiling, News18.com has learnt. The Central Drugs Laboratory in Kasauli on Tuesday cleared the first lot of Corbevax vaccine, which was sent for testing before Biological E can kickstart …

Grand cover-up: The Narendra Modi government's celebration of one billion COVID vaccine doses
3 years, 2 months ago

Grand cover-up: The Narendra Modi government's celebration of one billion COVID vaccine doses

The Hindu  

Administering over one billion cumulative doses of COVID vaccine within nine months since the COVID vaccination campaign began on January 16 is no mean achievement in a country with a population of 1.38 billion and diverse logistical difficulties. More significantly, with a vaccination rate of over 10 million doses a day on a consistent basis, China has fully vaccinated nearly …

Discover Related